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Abstract
In calcific tendinopathy (CT), calcium deposits in the
substance of the tendon, with chronic activity-related
pain, tenderness, localized edema and various degrees
of decreased range of motion. CT is particularly
common in the rotator cuff, and supraspinatus,
Achilles and patellar tendons. The presence of calcific
deposits may worsen the clinical manifestations of
tendinopathy with an increase in rupture rate, slower
recovery times and a higher frequency of post-
operative complications. The aetiopathogenesis of CT
is still controversial, but seems to be the result of an
active cell-mediated process and a localized attempt
of the tendon to compensate the original decreased
stiffness. Tendon healing includes many sequential
processes, and disturbances at different stages of
healing may lead to different combinations of
histopathological changes, diverting the normal
healing processes to an abnormal pathway. In this
review, we discuss the theories of pathogenesis
behind CT. Better understanding of the pathogenesis
is essential for development of effective treatment
modalities and for improvement of clinical outcomes.
Keywords: Calcific Tendinopathy, Calcific Deposits,
Tendons, Review
Introduction
In calcific tendinopathy (CT) calcium deposits in the
substance of the tendon. CT is particularly common in
the rotator cuff tendons (RCTs) and supraspinatus ten-
don, and Achilles tendon and patellar tendon. CT of the
rotator cuff is common in Caucasian populations, with a
reported prevalence of 2.7% to 22%, mostly affecting
women between 30 and 50 years. The most frequently
involved tendon is the supraspinatus tendon, and in 10%
of patients the condition is bilateral (Figure 1) [1]. The
nomenclature of this condition is confusing, and, for
example, in the shoulder terms such as calcific periar-
thritis, periarticular apatite deposition, and calcifying
tendinitis have been used [2]. We suggest to use the
terms ‘calcific tendinopathy’, as it underlines the lack of
a clear pathogenesis when the process is located in the
body of tendon, and ‘insertional calcific tendinopathy’, if
the calcium deposit is located at the bone-tendon
junction.
Calcific insertional tendinopathy of the Achilles tendon
manifests in different patients populations, including
young athletes and older, sedentary and overweight indi-
viduals [3]. Usually, radiographs evidence ossification at
the insertion of the Achilles tendon or a spur (fish-hook
osteophyte) on the superior portion of the calcaneus. CT
in this location is often associated with retrocalcaneal
bursitis or Haglund’s deformity. The incidence of inser-
tional tendinopathy of the Achilles tendon is not clear.
The incidence varies from 5% to the most common pre-
sentation in athletes [3]; calcifications of the main body
of the tendon are at best uncommon (Figure 2). CT of
the patellar tendon is rare, and most patients with patel-
lar tendinopathy show no evidence of ossification [4].
Most of the current treatment modalities are neither
effective nor evidence-based because of our poor under-
standing on the underlying pathogenesis of CT. We
review the present knowledge on this topic to stimulate
further research.
Clinical manifestation
Clinical manifestations of the calcific process within the
tendons include chronic activity-related pain, tenderness,
localized edema and various degrees of decreased range
of motion (ROM). CT of the rotator cuff shows a ten-
dency toward spontaneous resorption of the deposits and
symptoms often resolve spontaneously, although some
authors described persistent pain at long time follow-up
and persistent reduction of ROM [5,6]. Osteolysis of the
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greater tuberosity is an uncommon and distinctive form
of CT of the shoulder, and is associated with significantly
poorer clinical and functional outcome both before and
after surgical treatment [7]. Microscopic calcifications
which are not detectable at plain radiography can also
occur in chronic tendinopathy. A histological study
showed high incidence of small calcium deposits in
tendinopathic supraspinatus tendons [8]. Microscopic
calcium deposits are frequent also in diabetic patients [9].
The clinical course of insertional CT has been poorly
investigated, although experience suggests that pain
seems to improve in older patients even though the
insertional calcification persists. Generally, the presence
of calcific deposits worsens the clinical manifestations of
Figure 1 Bilateral calcific tendinopathy (CT) of the shoulder.
Figure 2 Insertional calcific tendinopathy (CT) of the Achilles tendon associated with CT of the main body of the tendon.
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tendinopathy with an increase in rupture rate, slower
recovery times and a higher frequency of post-operative
complications [10].
Historical review
As previously discussed, the nomenclature of CT is con-
fusing, perhaps in part because of the many terms classi-
cally used to describe localized deposits of calcium in
tendons [11], including calcifying tendinitis, calcific ten-
dinitis, calcified tendinitis, calcareous tendinitis, tendino-
sis calcarea, calcific periarthritis, periarticular apatite
deposit [10]. Some of them emphasise the extra-articular
location of the deposit, others mention the nature of the
compound found in the calcification or the process that
might explain its deposition.
At the beginning of the 1950s, it was clear that local
degeneration of the involved tendon precedes the
deposition of calcium salts [11], and that there may be a
constitutional predisposition.
Sandstrom, in 1938, speculated that necrosis of the
tendon secondary to local ischemia and vascular
changes was the first step to promote deposition of cal-
cified material [12]. Bishop believed that repetitive
minor trauma could induce rupture of the fibers of the
supraspinatus tendon, hyaline degeneration and the
deposition of calcium in the injured tendon [13]. The
hypothesis was later supported by Bosworth and collea-
gues [14]. Urist et al. and Uhthoff et al. suggested the
occurrence of an initial cartilage metaplasia of the ten-
don, followed by an active multifocal and cell-mediated
calcifying process [15,16]. Recently, Mohr and Bilger
described the process as beginning with the necrosis of
tenocytes with concomitant intracellular accumulation
of calcium, often in the form of microspheroliths or
psammomas [17].
Mineral components
Specimens of RCTs obtained during surgery consist of a
gritty mass of sandy material or a toothpaste-like fluid,
and the deposits were described as a white amorphous
mass composed of many small round or ovoid bodies.
Later, X-ray diffraction and infrared spectrometry and
other techniques identified the material of calcific
deposits as calcium carbonate apatite [18-20]. Computed
tomography studies of patellar tendon revealed the
three-dimensional structure of calcific deposits, which
have a porous structure throughout the tendon [18].
Few investigations have been performed on the role of
the types of carbonated apatite, although they have been
reported to be a single component in the calcific depos-
its [21]. Two different types of carbonate apatite com-
pose the calcific deposits, according to the position
which carbonate ions (CO3
2-) occupy in the hydroxyapa-
tite (HAP). They are defined as A-type carbonate apatite
and B-type carbonate apatite [22]. Gartner et al. [23]
observed that the macroscopic differences of calcific
deposits were not reflected in the mineralogical struc-
ture, and neither chemical compositional change nor a
change in the crystal lattice was observed. They stated
that no chemical dissolution process of the inorganic
material was responsible for the resorption activity in
the acute phase. More recently Chiou et al. studied the
chemical components in CT of the RCTs, and they
observed that different quantities of A- and B-type car-
bonated apatite changed in the formative, resting and
resorption phases [24]. They noted reduced amounts A-
type carbonate apatite and increased amounts located in
the B positions during the process of progressive calcifi-
cation. The same Authors classified calcific depositions
into four shapes according to ultrasonographic findings:
an arc shape, a fragmented or punctuated shape, a nod-
ular shape, and a cystic shape. They also found a statis-
tically significant association between the morphology of
the calcified deposits and the clinical symptoms of the
affected shoulder (Table 1).
Recently, matrix vesicles have been isolated in mature
porcine patellar tendons [25]. Matrix vesicles are small
extracellular organelles which are involved in minerali-
zation of the extracellular matrix in many tissues,
including bone and cartilage [26]. Previous studies
demonstrate the presence of matrix vesicles near calcific
deposition of the RCTs [16,27], and recently they have
been isolated also in the extracellular matrix of normal
patellar tendons [25]. The authors pointed out the
importance of extracellular matrix vesicles in pathoge-
netic mechanism of CT. In the normal matrix, the vesi-
cles are inhibited from mineralizing, but, in pathological
conditions, such as injuries or matrix degeneration
Table 1 Correlation between morphology, progressive calcification process and symptoms of the mineral components
of calcific tendinopathy (CT) of the rotator cuff, proposed by Chiou [24].
Calcific stage Phase Morphologic shape of calcific deposition Clinical symptoms
Pre-calcific stage Correlation not evaluated
Calcific stage Formative phase Arc or fragmented/punctuated Mild pain
Resting phase Nodular Moderate to severe pain
Resorptive phase Cystic Severe pain
Post-calcific stage Correlation not evaluated
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secondary to age or diabetes, they may be permitted to
mineralize.
Theories of pathogenesis
The aetiopathogenesis of CT is largely unknown, espe-
cially because it remains difficult to clarify the steps
which induce crystal deposition into the tendon.
Furthermore, biopsies of the pathologic RCTs are
obtained only towards the end of the natural history of
the condition, when patients are symptomatic [16].
Many different theories have been developed (see also
Table 2).
Reactive Calcification
Uhthoff and coworkers hypothesized that a favorable
environment permits an active process of cell-mediated
calcification, usually followed by spontaneous phagocytic
resorption [28]. They describe four stages in the calcify-
ing process of the rotator cuff: precalcific phase, calcific
phase, resorptive phase, and repair phase. All phases
may occur concomitantly in the same tendon. The pre-
calcific stage involves fibrocartilaginous metaplasia
within the tendon. In the second stage, the formative
phase, calcific deposits are formed. This stage is subdi-
vided into three phases: formative, resting, and resorp-
tive. Calcium crystals are deposited primarily in matrix
vesicles that coalesce to form large foci of calcification
separated by chondrocytes and fibrocartilaginous tissue
septae. The resting phase occurs when fibrocollagenous
tissue borders the foci of calcification, indicating termi-
nation of deposition. The resorptive phase is marked by
the appearance of thin-walled vascular channels at the
periphery of the deposit. Macrophages and multinu-
cleated giant cells then surround the deposit and phago-
cytose debris with calcium removal. In this phase, the
deposit exhibits a thick, creamy, or toothpaste-like
material that is often under pressure. The final stage
involves an attempt by tendon to heal. Nakase et al. [29]
clarified the nature of the multinucleated cells located
near the calcium deposits. These were positive for
cathepsin K [29], showing a typical osteoclast pheno-
type. Cathepsin K is a protease, it is a member of the
peptidase C1 protein family, is predominantly expressed
in osteoclasts, and it is involved in bone remodeling and
resorption [30]. Some years after these proposals were
made, osteopontin was observed in cells surrounding
tendon calcifications [31,32]. Osteopontin is a member
of the small integrin-binding ligand N-linked glycopro-
tein glycoprotein (SIBLING) family first identified in
1986 in osteoblasts. It plays important roles in many
physiological and pathological processes, including
wound healing and bone remodeling [33], but its role in
CT has not been clarified [32].
Endochondral Ossification
Achilles and patellar tendon calcifications are formed by
a process resembling endochondral ossification, with
bone formation and remodeling mediated by population
of osteoblasts and osteoclasts.
Benjamin and coworkers proposed a model of inser-
tional Achilles CT based on a rat study [34]. They sug-
gested that insertional CT could develop by endochondral
ossification of fibrocartilage at the enthesis of the Achilles
tendon. The calcific process begins in the enthesis and
grows into the tendon. Fibrocartilage cells appear by meta-
plasia from tenocytes. The fibrocartilage is then eroded,
and blood vessels invade the rows of fibrocartilage cells
from the underlying bone marrow. Finally, bone is depos-
ited and the spur is formed. No inflammatory cells or
microtears were identified. The authors believe that the
increased surface at the tendon-bone junction may repre-
sent an adaptive mechanism to increased mechanical
loads.
Lui et al. studied the histological features of collage-
nase-induced patellar tendon ossification in a rat model
[35]. Many chondrocyte-like cells and the absence of
infiltration of inflammatory cells were observed around
the calcific deposits. They found a marked loss of col-
lagen type I and an increase of collagen type II and type
X, which occurred mainly at the chondrocyte-like cells
and their surrounding matrix in the calcific deposits.
Collagen type II is typical of cartilage and fibrocartilage,
and it is resistant to compressive stresses. Type × col-
lagen is a short chain collagen which has been asso-
ciated with calcific cartilage and/or the expression of the
hypertrophic chondrocyte phenotype. It is a marker of
endochondral ossification. The same authors subse-
quently described an increased expression of collagen
Table 2 Different theories about etiopathogenesis of calcific tendinopathy (CT).
Type Cause Reference(s) by first author Year(s)
Degenerative calcification Vascular ischemia Sandstrom [12] 1938
Repetitive trauma Bishop [13] and Bosworth [14] 1939, 1941
Necrosis of tenocytes and intracellular calcium accumulation Mohr [17] 1990
Reactive calcification Active cell mediated process Uhthoff [27] 1997
Endochondral ossification Endochondral ossification of fibrocartilage at the enthesis of the tendon Benjamin [34] 2000
Chondral metaplasia Erroneous differentiation of tendon-derived stem cells (TDSCs) Rui [46] 2011
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type III and a high collagen type III/collagen type I ratio
[36]. The increase of collagen type III coincided with
thinner, less organized and weaker tendon. Histological
specimens of insertional calcific tendinopathy of Achilles
tendons showed a greater intensity of staining for col-
lagen type III than normal tendons [37], and higher
than normal expression of collagen types III mRNA was
detected high in human Achilles tendinopathy [38].
Chondrocyte markers were also evidenced in the clinical
samples of calcific insertional Achilles tendinopathy and
in rotator cuff tendinopathy [37,39].
Chondral Metaplasia
Other authors thought that ectopic bone derives from
metaplasia of tendon cells into osteogenic cells. Injection
of recombinant human bone morphogenetic protein-2
(rhBMP-2) [40] into the tendon increased ectopic bone
formation, indicating that the tendon consisted of cells
that were responsive to BMP [41] and were capable of
differentiating along the chondro-osseous pathway.
Mesenchymal stem cells are present in tendon tissues
[42]. Human and mouse tendons hold cells with univer-
sal stem cell characteristics which could differentiate
into chondrocytes and osteoblasts [43]. Rui et al. iso-
lated Tendon-Derived Stem Cells (TDSCs) from the
flexor tendon and patellar tendon of rats [44,45]. They
proposed that chondral metaplasia and ectopic ossifica-
tion may be caused by erroneous differentiation of ten-
don cells [46].
Which condition or stimulus is able to cause this erro-
neous differentiation of TDSCs? Many proteins could be
involved in tendon degeneration, calcification and rear-
rangement processes, playing different roles in the var-
ious phases of calcification and resorption. Among the
possible candidates are bone morphogenetic proteins
(BMPs) and transglutaminases (TGs). Recently, Zang
and Wang suggested that BMP-2-mediated effects on
human TDSCs may contribute to the formation of calci-
fic deposits in CT [47]. We observed an increased
expression of osteopontin, cathepsin K and TG2 mRNA
in the calcific areas of the supraspinatus tendon as com-
pared to what observed in the normal tissue [48]. TG2
is ubiquitously expressed, and plays a role in a variety of
cellular processes, including the crosstalk between
macrophages and apoptotic cells, glucose tolerance and
other processes. It is also important in maintaining the
structural integrity of tendons and it could be involved
in tendon repair [49]. The increased expression of osteo-
pontin and TG2 could thus be compatible with their
increased production in the calcific area, probably by
osteoclast-like cells involved in the resorptive phase [29].
The mRNA and protein expression of major proteo-
glycans of extracellular matrix, including decorin, aggre-
can, biglycan and fibromodulin and their relationship
with ectopic chondrogenesis, ossification and loss of
matrix organization, has been observed in a calcific ten-
dinopathy model [36]. Decorin, aggrecan, biglycan and
fibromodulin are small leucine rich repeated proteogly-
cans (SLRPs), which participate in collagen-fibril forma-
tion, and their expression patterns are altered in chronic
tendinopathy [50]. Decorin is a component of connec-
tive tissue, binds to type I collagen fibrils, and plays a
role in matrix assembly [51]. It is the most abundant
SLRP found in tendon mid-substance. Aggrecan and
biglycan are common in the fibrocartilaginous regions
of the enthesis. Aggrecan plays an important role in the
adaptation to compressive loads. Fibromodulin partici-
pates in the assembly of the extracellular matrix, and it
interacts with type I and type II collagen fibrils [52]. A
sustained or increased expression of decorin, aggrecan,
biglycan and fibromodulin was found in this calcified
tendinopathy model [36]. However, the presence of
ectopic calcification in Achilles, patellar and quadriceps
tendons was also reported in biglycan and fibromodulin
knockout mice [53]. Another important feature of
SLRPs is their ability to modulate the activity of the
resident cell population by binding and sequestering
growth factors [54,55]. The differentiation of tendon
progenitor cells into chondrocytes and bone cells was
modulated by the expression of biglycan and fibromodu-
lin [56]. In normal tendon healing, TDSCs would prolif-
erate and differentiate into tenocytes, but in particular
conditions, they can differentiate into chondrocytes or
osteoblasts, causing the deposition of the ‘wrong’ extra-
cellular matrix and calcific deposits, resulting in failed
healing and pain. The mechanism leading to the erro-
neous differentiation of TDSCs is not clear. It could be
modulated by the expression of biglycan and fibromodu-
lin, and by the expression of chondro-ostogenetic BMPs,
such as BMP-2, BMP-4 and BMP-7, which were over-
expressed in CT models [57]. Rui et al. therefore
hypothesized that the erroneous differentiation of
TDSCs into chondrocytes or osteoblasts instead of teno-
cytes could be the pathogenetic mechanism of calcifying
tendinopathy [46]. Aberrant differentiation of stem cells
has been postulated to be the cause of other disorders,
including vascular calcification [58], skin calcification
[59] and skeletal calcification [60].
Predisposing Factors
An association between CT and diabetes and thyroid
disorders has been shown, but the precise mechanism is
still unknown [1]. Patients with associated endocrine
disorders present earlier onset of symptoms, longer nat-
ural history, and they undergo surgery more frequently
compared to a control population [61,62]. More than
30% of patients with insulin-dependent diabetes have
tendon calcification [63]. The exposure of proteins to
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high levels of sugar moieties cause the glycosylation of
several extra-cellular matrix proteins, which can modify
the extracellular matrix by cross-linking proteins. In an
animal study, tenocytes obtained from porcine patellar
tendon have been incubated with glycated type I col-
lagen, which increased Tg activity. This may represent
an additional pathway mediating pathologic changes and
could contribute to CT in diabetes [62].
A familial predisposition and inherited genetic compo-
nents have also been postulated as a cause of CT in some
circumstances [64-67]. Variants within the COL5A1 [68],
tenascin C [69] and matrix metalloproteinase 3 (MMP3)
genes [70] are associated with increased risk of Achilles
tendon injuries. CT of the RCTs have been observed in
children, and hence it cannot be related to degenerative
changes [71] (Figure 3). Therefore, some genetic variants
could modify the susceptibility of tendons to the matrix
abnormalities observed in tendinopathy [72].
Discussion and Future perspectives
The aetiopathogenesis of CT is still controversial, espe-
cially because it remains difficult to clarify the first steps
causing this condition and those involved in the devel-
opment of calcifications.
Rather than being formed by precipitation of inorganic
ions, CT results from an active cell-mediated process in
which resident progenitor cells with multidifferentiation
potential may play a determinant role [73].
Many different factors such as acute injury, repetitive
microtrauma, and chemical-induced injury may cause
damage to the tendon and start the natural healing pro-
cess. Tendon healing includes many sequential processes
such as matrix synthesis and remodeling, synthesis of
pro-inflammatory cytokines, neovascularization, neural
modulations, recruitment of healing cells, multipotent
cells, TDSCs, proliferation, apoptosis [74]. Disturbances
at different stages of healing may lead to different com-
binations of histopathological changes. The normal heal-
ing processes are then diverted onto an abnormal
pathway (Figure 4). Clinical features such as chronic
pain, swelling, functional limitations and tendon rup-
tures are the consequences.
Since ossified tendons will have increased stiffness,
ossification can be seen as a localized attempt to com-
pensate for the original decreased stiffness of the weak
tendon. It is possible that the erroneous differentiation of
tendon progenitor cells into chondrocytes or osteoblasts
instead of tenocytes may contribute to the pathogenesis
of CT. The mechanism leading to the erroneous differen-
tiation of TDSCs is not completely understood. Probably,
the expression of BMPs, biglycan, fibromodulin and an
unfavorable micro-environment induced by overuse
modify the natural healing process of the tendon. Con-
servative management modalities such as non-steroidal
anti-inflammatory drugs (NSAIDs) or corticosteroids are
often prescribed, and may further influence the pathways
of the failed healing [75]. NSAIDs could modulate tendon
cell proliferation [76,77], the expression of extracellular
matrix components [78] and degradative enzymes in cells
culture studies [46]. Corticosteroids can induce a
Figure 3 Calcific tendinopathy (CT) of the subscapularis tendon in a 13-years-old boy.
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fibrocartilaginous phenotype in tendon cells [78], and
induce osteogenic differentiation in human spinal liga-
ment derived cells [79].
Many questions remain unanswered about the patho-
genesis of CT. Calcium carbonate apatite appears the only
component of calcific deposits, but inorganic component
of Achilles and patellar CT has been less investigated than
CT of the RCTs. Histological and imaging studies show
that the three-dimensional structure of calcific deposits is
quite different. Calcific depositions in the RCTs appear as
a toothpaste-like fluid, while calcific deposits in the
Achilles and patellar tendons have a porous structure [35]
and a vascular core [34]. Therefore, we can speculate that
their mineralogical structure could also be different.
‘Calcific tendinopathy’ and ‘insertional calcific tendino-
pathy’ are caused by two distinct pathogenetic mechan-
isms. In RCTs, degenerative changes in the extracellular
matrix seem to play an important role for the formation
of calcific deposits. The pathogenesis of CT involves
matrix vesicles, macrophages and multinucleated giant
cells with a typical osteoclast phenotype, producing a
toothpaste-like material [25,29]. No vascular invasion
has been documented. This process has not been
observed in other tendons. Recently, Gohr et al. eluci-
dated the role of matrix vesicles also in the patellar ten-
don [25], but, as the enthesis was removed, this model
is more similar to a CT of the main body of the tendon
than to an insertional CT. We also think that degenera-
tive changes cannot be solely responsible, because we
are not able to explain the deposition of calcium salt in
twin brothers and children only with a reactive degen-
erative theory [65,66,71].
The mechanism of insertional CT has been clarified by
Benjamin and coworkers, and essentially accepted world-
wide [34] (Table 3). Increased vascularity in insertional
Achilles tendinopathy was observed also by other authors
[37].
CT of the rotator cuff has been investigated with histolo-
gical studies of specimens obtained from human biopsies,
while the study of CT of Achilles and patellar tendons is
based on animal models of collagenase-induced tendinopa-
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Figure 4 The abnormal pathway that may lead to calcific tendinopathy (CT).
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of CT of the rotator cuff can be compared to CT of the
Achilles and patellar tendons. Moreover, no pathogenetic
studies on the rotator cuff have been published since the
late 1970s, and no animal CT studies are present in litera-
ture [80]. We do not know why the calcific deposits of the
rotator cuff involve the main body of the tendon, while the
most common presentation of CT in the Achilles tendon is
insertional. Animal models of CT of RC seem necessary to
understand its pathogenesis. No histological and epidemio-
logical studies on CT of the main body of Achilles tendon
are published.
Furthermore, no clinical or imaging classification has
been published in the literature, except for the CT of RCTs
[1]. Also, it is not clear whether the gross morphological
anatomy of tendons (for example, the RC is a flat tendon,
while the Achilles tendon is cylindrical) plays a role.
The involvement of mesenchymal stem cells (MSCs)
in the pathogenesis of the CT process [46] and the role
of autologous growth factors have been postulated, but
not clarified [54,55].
While emerging data seem to indicate an association
between tendinopathies and endocrine disorders such as
diabetes, hypercholesterolemia, hypertriglyceridemia,
thyroid disorders, and estrogen levels alterations [81,82],
the association with CT is unclear, and no physiopatho-
logical investigations have been performed.
Conclusions
The aetiopathogenesis of CT is still controversial, but it
seems to be the results of an active cell-mediated
process. We advocate use of the terms ‘calcific tendino-
pathy’ and ‘insertional calcific tendinopathy’ to differ-
entiate conditions that seem to be caused by two
different pathogenetic mechanisms. Better understand-
ing of the pathogenesis is essential for development of
effective treatment modalities and for the improvement
of clinical outcomes.
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